Verition Fund Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.57M Buy
+257,435
New +$3.86M 0.02% 846
2026
Q1
– Sell
-281,196
Closed -$4.34M – 3395
2025
Q4
$4.34M Buy
281,196
+112,653
+67% +$2.07M 0.02% 972
2025
Q3
$3.65M Sell
168,543
-88,914
-35% -$1.98M 0.02% 1470
2025
Q2
$5.72M Sell
257,457
-898,488
-78% -$20M 0.03% 974
2025
Q1
$27.5M Buy
+1,155,945
New +$27.4M 0.13% 137
2024
Q3
– Sell
-42,866
Closed -$1.02M – 3485
2024
Q2
$1.02M Buy
+42,866
New +$1.1M 0.01% 1659
2023
Q3
– Sell
-4,962
Closed -$223K – 2647
2023
Q2
$223K Buy
+4,962
New +$189K ﹤0.01% 1765

Other funds holding SGRY

Verition Fund Management's SGRY Position: Q3 2026 in Review

Verition Fund Management opened a new position in Surgery Partners (SGRY) in Q3 2026: 257,435 shares worth $3.57M. The stake represents 0.02% of the portfolio and ranks #846 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in SGRY as recently as Q4 2025.

Verition Fund Management first reported a position in SGRY in Q2 2023 and has held it in 7 quarters since. The position peaked at $27.5M in Q1 2025. 191 funds tracked by Wall St. Rank hold SGRY as of Q3 2026.

  • Verition Fund Management held 257,435 shares of Surgery Partners worth $3.57M as of Q3 2026.
  • Surgery Partners was a new Verition Fund Management position in Q3 2026.
  • Surgery Partners made up 0.02% of Verition Fund Management's portfolio in Q3 2026, its #846 holding.
  • Verition Fund Management first reported a position in Surgery Partners in Q2 2023 and has held it in 7 quarters since.
  • Verition Fund Management's Surgery Partners position peaked at $27.5M in Q1 2025.
  • 191 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2026.

Based on Verition Fund Management's 13F filing for Q3 2026, filed 13 Nov 2026.